- Home
- ALLO vs TCBX Comparison
ALLO vs TCBX Comparison
Compare ALLO & TCBX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | ALLO | TCBX |
|---|---|---|
| Founded | 2017 | 2008 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Biological Products (No Diagnostic Substances) | Banks |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 707.6M | 659.5M |
| IPO Year | 2018 | 2021 |
Fundamental Metrics
Financial Performance| Metric | ALLO | TCBX |
|---|---|---|
| Price | $1.96 | $43.58 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 15 | 3 |
| Target Price | $8.35 | ★ $45.00 |
| AVG Volume (30 Days) | ★ 7.8M | 123.7K |
| Earning Date | 05-07-2026 | 04-22-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | 34.09 | ★ 36.33 |
| EPS | N/A | ★ 0.88 |
| Revenue | N/A | N/A |
| Revenue This Year | N/A | $29.99 |
| Revenue Next Year | $142,416.42 | $10.14 |
| P/E Ratio | ★ N/A | $50.42 |
| Revenue Growth | N/A | ★ N/A |
| 52 Week Low | $0.99 | $35.60 |
| 52 Week High | $4.46 | $44.39 |
Technical Indicators
Market Signals| Indicator | ALLO | TCBX |
|---|---|---|
| Relative Strength Index (RSI) | 44.13 | 68.64 |
| Support Level | $1.56 | $36.41 |
| Resistance Level | $1.92 | N/A |
| Average True Range (ATR) | 0.12 | 1.32 |
| MACD | -0.01 | 0.34 |
| Stochastic Oscillator | 40.82 | 99.61 |
Price Performance
Historical ComparisonAbout ALLO Allogene Therapeutics Inc.
Allogene Therapeutics Inc is a clinical stage immuno-oncology company pioneering the development of genetically engineered allogeneic T cell product candidates for the treatment of cancer and autoimmune diseases. Its pipeline includes "off-the-shelf" T cell candidates designed to target cancer cells or eliminate autoreactive cells in patients with autoimmune disorders. Its three core programs are: Large B-Cell Lymphoma (LBCL), Autoimmune Disease (AID) and Renal Cell Carcinoma (RCC).
About TCBX Third Coast Bancshares Inc.
Third Coast Bancshares Inc is a bank holding company. It focuses on providing commercial banking solutions to small and medium-sized businesses and professionals with operations in its markets. The bank operates twenty branches in the Greater Houston, Dallas-Fort Worth, and Austin-San Antonio markets, one branch in Ballinger, Texas, and one branch in Detroit, Texas. The company operates through one segment, community banking, It generates the majority of its revenue from interest on loans, customer service, and loan fees.